Drug Profile
KA 05A
Alternative Names: KA-05ALatest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator kaleo
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 21 Jan 2022 Discontinued - Clinical-Phase-Unknown for Unspecified (unspecified route), before January 2022 (Kaleo pipeline, January 2022)
- 28 Oct 2019 No recent reports of development identified for clinical-Phase-Unknown development in Unspecified in Unknown
- 25 Aug 2016 Clinical trials in Undefined indication (unspecified route) before August 2016